MEDIFAST (MED)
(Delayed Data from NYSE)
$18.60 USD
-0.23 (-1.22%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $18.58 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.60 USD
-0.23 (-1.22%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $18.58 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden
by Zacks Equity Research
Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden
Post Holdings (POST) Q3 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
Post Holdings (POST) third-quarter performance reflects gains from acquisitions, recovery in foodservice channel as well as strong brand performance across certain categories.
B&G Foods (BGS) Q2 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
B&G Foods (BGS) second-quarter fiscal 2021 results reflect lower earnings and sales on unfavorable year-over-year comparisons. Also, input cost inflation affected quarterly results.
5 Top-Performing Liquid Stocks to Snap Up for Higher Returns
by Zacks Equity Research
Here are five top-ranked liquid stocks, Magnolia Oil & Gas (MGY), Medifast (MED), Textron (TXT), ConocoPhillips (COP) and Steven Madden (SHOO), which investors can consider for attractive returns.
TreeHouse Foods (THS) Q2 Earnings Meet Estimates, Stock Down
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter 2021 results reflect lower earnings and sales. Management curtails 2021 guidance.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Medifast (MED) Surpasses Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Strength in independent OPTAVIA Coaches along with gross margin expansion and lower SG&A expense rate aids Medifast (MED) in Q2.
Kellogg's (K) Q2 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results reflect tough comparisons with the year-ago period, though away-from-home channel recovery and emerging market strength were upsides.
Medifast (MED) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 20.00% and 7.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 sales and earnings decline year over year on softness across United States business.
Here's How Post Holdings (POST) is Placed Before Q3 Earnings
by Zacks Equity Research
Post Holdings' (POST) third-quarter fiscal 2021 results are likely to reflect gains from its prudent buyouts as well as strength across the BellRing Brands segment.
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
Everything Worth Noting Ahead of Kellogg's (K) Q2 Earnings
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results are likely to reflect escalated costs and moderation in at-home consumption-related demand. That said, the company's brand strength has been a driver.
B&G Foods (BGS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
B&G Foods' (BGS) second-quarter 2021 results are likely to reflect escalated input costs for ingredients, packaging and transportation, though rising online sales have been aiding.
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.
Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.
Medifast (MED) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) second-quarter 2021 results are likely to reflect continued strength in OPTAVIA lifestyle solution and coaching support system.
Kraft Heinz (KHC) Gears Up to Post Q2 Earnings: What in Store?
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 performance is likely to reflect adverse impacts from escalated cost inflation. Nevertheless, focus on operating model bodes well.
Service Corporation's (SCI) Q2 Earnings Top Estimates, View Raised
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
Hershey's (HSY) Q2 Earnings Surpass Estimates, Sales Up Y/Y
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Management raises 2021 net sales view.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results reflect higher sales and earnings on strength across Mexico, the U.K. and Europe as well as the U.S. operations.
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez (MDLZ) Q2 Earnings Match Estimates, Revenues Beat
by Vrishali Bagree
Mondelez International's (MDLZ) second-quarter 2021 results reflect a rise in earnings and sales. A solid first-half performance led to a raised organic revenue growth view, though high costs are a concern.
Clorox (CLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.
Freshpet (FRPT) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Freshpet's (FRPT) second-quarter performance is likely to have gained from strong consumption trends. However, rising freight and beef costs are a concern.